Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect
Abstract Ouabagenin (OBG) is an aglycone of the cardiotonic steroid ouabain and until now was considered a biologically inactive biosynthetic precursor. Herein, we revealed that OBG functions as a novel class of ligand for the liver X receptor (LXR). Luciferase reporter assays and in silico docking...
Guardado en:
Autores principales: | Satoru Tamura, Maiko Okada, Shigeaki Kato, Yasuharu Shinoda, Norifumi Shioda, Kohji Fukunaga, Kumiko Ui-Tei, Minoru Ueda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b859fcce77d6432195f802e39f6294b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
por: Gregory Segala, et al.
Publicado: (2017) -
Activation of LXRα improves cardiac remodeling induced by pulmonary artery hypertension in rats
por: Yibo Gong, et al.
Publicado: (2017) -
Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice
por: Maud Voisin, et al.
Publicado: (2021) -
LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis O, et al.
Publicado: (2018) -
Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Joshua A. Levine, et al.
Publicado: (2021)